| Results summary | View all lists in GO:BiolProc | View all genes in D07A.profile.ud50 |
regulation of biological process Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. enrichment: 1.51-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 203973_S_AT | CEBPD | R | CCAAT/enhancer binding protein (C/EBP), delta | ||||||||||
| 210260_S_AT | TNFAIP8 | G | tumor necrosis factor, alpha-induced protein 8 | ||||||||||
| 218724_S_AT | TGIF2 | R | TGFB-induced factor homeobox 2 | ||||||||||
| 211959_AT | IGFBP5 | S | insulin-like growth factor binding protein 5 | ||||||||||
| 201939_AT | PLK2 | P | S | polo-like kinase 2 (Drosophila) | |||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 203372_S_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 203543_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 208078_S_AT | SNF1LK | D | P | S | SNF1-like kinase | ||||||||
| 205440_S_AT | NPY1R | E | S | neuropeptide Y receptor Y1 | |||||||||
| 213668_S_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 204526_S_AT | TBC1D8 | G | S | TBC1 domain family, member 8 (with GRAM domain) | |||||||||
| 214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
| 211668_S_AT | PLAU | X | P | S | plasminogen activator, urokinase | ||||||||
| 201110_S_AT | THBS1 | D | X | C | thrombospondin 1 | ||||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203358_S_AT | EZH2 | D | P | R | enhancer of zeste homolog 2 (Drosophila) | ||||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 201417_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 210336_X_AT | MZF1 | R | myeloid zinc finger 1 | ||||||||||
| 36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
| 205479_S_AT | PLAU | X | P | S | plasminogen activator, urokinase | ||||||||
| 201418_S_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 204924_AT | TLR2 | G | X | S | toll-like receptor 2 | ||||||||
| 215001_S_AT | GLUL | C | glutamate-ammonia ligase (glutamine synthetase) | ||||||||||
| 205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 201416_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 39402_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 201585_S_AT | SFPQ | X | R | splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | |||||||||